Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

Specifically, the latest guidelines say that researchers should not use any stem cell-based embryo models to try to start a ...

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Telehealth is increasingly an option for pregnant people seeking abortions in the United States — even those who live in ...

A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic ...

Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...

Plus more pharma news from the Pharmalittle newsletter.

Because of the unglamorous, underfunded, lifesaving work of the World Health Organization, the National Institutes of Health, ...

In every way, a study published this January in a major medical journal was a win for UnitedHealth Group. It showed that ...

He could appeal the decision to the director of the NIH, Dr. Jay Bhattacharya. It was a name Garber knew exceptionally well. For more than three decades, Garber had nurtured Bhattacharya’s career, ...

Good morning. A lot happened at federal health agencies this weekend. Scroll down for everything we know about the shooting at CDC headquarters and the sudden return of Vinay Prasad to the FDA. A lot ...